V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003255 | 10002078 | 1.65 | 98.4 | Disease modification (D) | 2019-01-14 | 2019-01-14 | Rituximab | N | N | 10467296 | RITUXIMAB |
| 10003256 | 10002079 | 1.82 | 58.7 | Palliative (P) | 2018-10-26 | 2018-11-05 | EOX | N | N | 10467306 | EOX |
| 10003257 | 10002079 | 1.72 | 76.3 | Palliative (P) | 2019-01-07 | 2019-01-07 | Enzalutamide | 02 | N | 10467306 | ENZALUTAMIDE |
| 10003258 | 10002080 | null | 91.85 | Palliative (P) | 2017-11-29 | 2017-12-06 | EOX | N | N | 10467404 | EOX |
| 10003259 | 10002081 | 1.7 | 80.2 | Palliative (P) | 2016-12-07 | 2016-12-07 | Gemcitabine weekly | N | N | 10467415 | GEMCITABINE |
| 10003260 | 10002082 | 1.83 | 0 | Palliative (P) | 2017-08-14 | 2017-08-16 | ECX | N | N | 10467497 | ECX |
| 10003261 | 10002082 | 1.75 | 81.5 | Palliative (P) | 2016-03-12 | 2016-03-12 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 10467497 | GEMCITABINE |
| 10003262 | 10002083 | 1.78 | 0 | null | 2014-07-07 | 2014-07-16 | CVP R | N | N | 10467585 | CVP R |
| 10003263 | 10002084 | 1.8 | 86 | Palliative (P) | 2018-07-05 | 2018-07-13 | Enzalutamide | 02 | N | 10467638 | ENZALUTAMIDE |
| 10003264 | 10002085 | 1.68 | 63.6 | Curative (C) | 2013-10-26 | 2013-11-11 | Cisplatin + Pemetrexed | N | N | 10467641 | CISPLATIN + PEMETREXED |
| 10003265 | 10006386 | 1.62 | 65 | Palliative (P) | 2018-12-31 | 2019-01-07 | Cisplatin + Pemetrexed | 2 | N | 10467649 | CISPLATIN + PEMETREXED |
| 10003266 | 10002086 | 1.8 | 77 | Disease modification (D) | 2013-03-15 | 2013-03-16 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 10467810 | RITUXIMAB |
| 10003267 | 10002087 | 1.63 | 64.2 | Palliative (P) | 2017-01-13 | 2017-01-27 | PEMBROLIZUMAB | N | N | 10467824 | PEMBROLIZUMAB |
| 10003268 | 10002088 | 1.7 | 109.4 | Adjuvant (A) | 2018-03-21 | 2018-04-06 | PEMBROLIZUMAB | N | N | 10467866 | PEMBROLIZUMAB |
| 10003269 | 10002089 | null | 0 | Palliative (P) | 2016-12-10 | 2016-12-11 | Enzalutamide | null | N | 10467913 | ENZALUTAMIDE |
| 10003270 | 10006387 | 1.78 | 64.6 | Adjuvant (A) | 2013-09-25 | 2013-10-03 | Cisplatin + Vinorelbine (IV) | N | Y | 10467992 | CISPLATIN + VINORELBINE |
| 10003271 | 10002090 | 0 | 110.1 | Palliative (P) | 2015-09-23 | 2015-10-07 | Enzalutamide | N | N | 10468010 | ENZALUTAMIDE |
| 10003272 | 10002090 | 1.84 | null | Disease modification (D) | 2013-07-11 | 2013-07-15 | Hydroxycarbamide | N | null | 10468010 | HYDROXYCARBAMIDE |
| 10003273 | 10002090 | 1.77 | 60.4 | Adjuvant (A) | 2016-09-13 | 2016-09-15 | Hydroxycarbamide | N | N | 10468010 | HYDROXYCARBAMIDE |
| 10003274 | 10002091 | 1.81 | 109.3 | null | 2013-11-18 | 2013-11-20 | Rituximab (Maintenance) | 02 | N | 10468130 | RITUXIMAB |
| 10003275 | 10002091 | 1.68 | 106.3 | Palliative (P) | 2018-01-21 | 2018-03-06 | EOX | 02 | N | 10468130 | EOX |
| 10003276 | 10008071 | 1.48 | 48.4 | Adjuvant (A) | 2014-04-16 | 2014-04-16 | GEMCITABINE | N | N | 10468177 | GEMCITABINE |
| 10003277 | 10002092 | null | 66.1 | Palliative (P) | 2017-09-04 | 2017-09-12 | PEMBROLIZUMAB | N | N | 10468223 | PEMBROLIZUMAB |
| 10003278 | 10002093 | 1.63 | 59 | Disease modification (D) | null | 2015-08-25 | R GCVP | 02 | null | 10468236 | CVP R |
| 10003279 | 10002094 | null | 74.4 | Adjuvant (A) | 2017-03-31 | 2017-04-16 | CARBOPLATIN + VINORELBINE | N | N | 10468239 | CARBOPLATIN + VINORELBINE |
| 10003280 | 10002095 | 1.69 | 70.9 | Palliative (P) | null | 2018-12-29 | Carboplatin + Vinorelbine Oral | N | N | 10468282 | CARBOPLATIN + VINORELBINE |
| 10003281 | 10002096 | 1.54 | null | Palliative (P) | 2017-01-13 | 2017-01-13 | Trial Unspecified | 01 | N | 10468337 | TRIAL |
| 10003282 | 10006390 | 1.78 | 54.7 | Palliative (P) | 2016-06-12 | 2016-06-28 | Trial Unspecified | Y | N | 10468379 | TRIAL |
| 10003283 | 10002097 | 1.84 | 86 | Curative (C) | 2018-06-12 | 2018-07-09 | CVP R | N | null | 10468393 | CVP R |
| 10003284 | 10002098 | 0 | 83.8 | Palliative (P) | 2018-07-17 | 2018-07-19 | Cisplatin + Pemetrexed | 02 | N | 10468414 | CISPLATIN + PEMETREXED |
| 10003285 | 10006391 | 1.68 | null | Palliative (P) | 2018-07-03 | 2018-07-16 | Cisplatin + Pemetrexed | 02 | N | 10468455 | CISPLATIN + PEMETREXED |
| 10003286 | 10002099 | 1.8 | 92.2 | Disease modification (D) | 2016-02-08 | 2016-02-11 | Hydroxycarbamide | N | N | 10468471 | HYDROXYCARBAMIDE |
| 10003287 | 10002100 | 1.78 | null | Palliative (P) | 2018-08-03 | 2018-08-20 | Cisplatin + Pemetrexed | N | N | 10468476 | CISPLATIN + PEMETREXED |
| 10003288 | 10002101 | 1.63 | 59 | Palliative (P) | 2017-03-16 | 2017-03-27 | EOX | N | N | 10468480 | EOX |
| 10003289 | 10002102 | 1.85 | 73 | Palliative (P) | 2016-02-19 | 2016-03-26 | Enzalutamide | 02 | N | 10468504 | ENZALUTAMIDE |
| 10003290 | 10002103 | 1.65 | 65 | null | 2017-03-08 | 2017-03-08 | R GCVP | N | N | 10468579 | CVP R |
| 10003291 | 10002103 | 1.61 | 63.8 | Disease modification (D) | 2016-01-15 | 2016-01-17 | Hydroxycarbamide | N | N | 10468579 | HYDROXYCARBAMIDE |
| 10003292 | 10002103 | null | null | Palliative (P) | 2018-06-10 | 2018-06-10 | Hydroxycarbamide | N | N | 10468579 | HYDROXYCARBAMIDE |
| 10003293 | 10002103 | null | null | Palliative (P) | null | 2015-04-06 | PEMBROLIZUMAB | N | null | 10468579 | PEMBROLIZUMAB |
| 10003294 | 10002103 | 1.72 | 98.3 | Palliative (P) | 2016-01-05 | 2016-01-13 | GEMCITABINE | 02 | N | 10468579 | GEMCITABINE |
| 10003295 | 10002104 | 1.68 | null | Palliative (P) | 2017-05-14 | 2017-05-22 | PEMBROLIZUMAB | 02 | N | 10468687 | PEMBROLIZUMAB |
| 10003296 | 10002105 | 1.61 | 78.5 | Palliative (P) | 2018-06-11 | 2018-06-21 | Cisplatin + Pemetrexed | 2 | null | 10468718 | CISPLATIN + PEMETREXED |
| 10003297 | 10002106 | 1.75 | 88.1 | Palliative (P) | 2015-01-27 | 2015-02-03 | Cisplatin + Pemetrexed | N | N | 10468727 | CISPLATIN + PEMETREXED |
| 10003298 | 10002107 | 0 | null | Palliative (P) | 2017-11-30 | 2017-12-03 | Cisplatin + Pemetrexed | 02 | N | 10468775 | CISPLATIN + PEMETREXED |
| 10003299 | 10002108 | 1.72 | 78.5 | Not known (9) | null | 2018-05-29 | Carboplatin + Vinorelbine IV | N | N | 10468787 | CARBOPLATIN + VINORELBINE |
| 10003300 | 10002109 | 1.8 | 66.3 | Palliative (P) | 2017-05-08 | 2017-05-23 | ABVD | N | N | 10468805 | AZACITIDINE |
| 10003301 | 10002110 | 1.6 | 56 | Neo-adjuvant (N) | 2018-04-28 | 2018-05-04 | CAPECITABINE + RT | 2 | Y | 10468892 | CAPECITABINE + RT |
| 10003302 | 10002110 | null | null | Adjuvant (A) | 2018-02-01 | 2018-03-10 | FLUOROURACIL + MITOMYCIN + RT | N | N | 10468892 | IMATINIB |
| 10003303 | 10002111 | 1.76 | 67.3 | null | 2016-11-13 | 2016-11-18 | CAPECITABINE + RT | N | Y | 10469044 | CAPECITABINE + RT |
| 10003304 | 10002112 | 1.85 | 71 | Adjuvant (A) | 2015-03-11 | 2015-03-15 | IMATINIB | N | N | 10469047 | ABIRATERONE |